Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
This study has been completed.
Study NCT00663403   Information provided by University of Michigan
First Received: April 18, 2008   Last Updated: May 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critically Ill
Hemodialysis
Additional conditions recognized in this trial
Critical Illness
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Interventions listed in this trial
Daptomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Michigan
Cubist Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services